Asthma is a rare cause of childhood mortality. However, an increase in mortality in young New Zealand asthmatics noted first in 1977 and continuing over the next five years caused concern. ' The increase brought the New Zealand mortality rate for childhood asthma to over three times that of the United Kingdom.2 Interaction between newly available sustained release theophylline and inhaled beta agonist was suggested as a possible reason for the rising mortality.3 Few series of childhood asthma deaths have been reported, and, apart from one community based study of 30 deaths over a period of 20 years,4 all have been hospital based populations. [5] [6] [7] [8] This paper reviews all deaths from asthma in children below the age of 15 identified during a two year national study of mortality from asthma in New Zealand.9 6 
Methods
Deaths in all age groups, certified as due to or related to asthma, between 1 August 1981 and 31 July 1983 inclusive in people usually resident in New Zealand were investigated.9 The criterion for inclusion in the study was the use of the words 'asthma', 'asthmatic', or 'asthmaticus' in Part I of the death certificate or on a coroner's report. Cases were identified by monthly regional searches of death certificates and a quarterly search of all certificates at the office of the Registrar General of Births, Deaths, and Marriages. Within four months of death an appropriate family member, the general practitioner, and any specialists consulted were interviewed and hospital records reviewed.
Ethnicity was taken as that stated by the relative interviewed. Data Characteristics of asthma and its management (Table) . In six cases asthma had developed during the first year of life and in the remainder by the age of 4. Eczema was present in 10 and hay fever without eczema in two. All except one child had a family history of asthma, involving first or second degree relatives. During the year before death asthma was considered by the general practitioner to be improving in five children, unchanged in four, but worsening in seven. Even when at their best in the last year, four were breathless on mild exertion and two breathless even on dressing. Only five children had ever had pulmonary function tests performed by their general practitioner. Of the 14 children aged 8 and over and considered old enough to use peak expiratory flowmeters, 10 had never done so, and only two were using meters regularly at home.
Ten of the 16 children had had two or more emergency visits to their general practitioner or Four of the six children with home nebulisers had used these during the last few hours of life when asthma was increasing in severity. Medical advice was obtained by telephone in two of these cases, but other appropriate treatment was not given. Overreliance on a home nebuliser, which was used up to two hourly for 10 and 16 hours, seemed to lead to delay in beginning more aggressive treatment in these two cases. The use of a home nebuliser did not adversely affect management of the other two children. Delays in obtaining help in these were due to failure to appreciate the severity of the attack or reluctance to call for help.
Because of the rapidity of deterioration, the deaths of two children were regarded as unavoidable. A two year old known to have asthma, apparently well apart from an upper respiratory tract infection, was found dead two and a half hours after being put to bed. Autopsy showed mucous plugging of bronchi as well as acute bronchiolitis. A 12 year old with moderately severe asthma well controlled with daily oral steroids and appropriate inhaled drugs died within five minutes of the onset of the attack. His peak expiratory flow rate one and a half hours earlier had been normal, although he then had symptoms of influenza. The physicians classified the deaths of three other children who had precipitous attacks as possibly unavoidable.
In the remaining 11 children avoidable factors contributed to the fatal outcome. In four children long term treatment was inadequate due either to attitudes of the family (one strongly antagonistic to any treatment with drug,s, the other accepting asthma with resignation and using minimal treatment) or the medical advisers (two cases). 
Discussion
The mortality rate from asthma in New Zealand children is approximately three times that of the United Kingdom.2 Possible reasons for this include a higher prevalence of asthma, greater severity, or poorer management. There are reports that the prevalence of asthma in New Zealand is higher than that in the United Kingdom." -'3 Formal comparisons of severity of asthma have yet to be undertaken, but physicians and paediatricians employed in the United Kingdom before coming to New Zealand consistently state that asthma in New Zealand is more severe and less responsive to treatment. 14 That all childhood deaths from asthma in our study occurred outside hospital may reflect a greater severity and a shorter time course of fatal asthma.
The New Zealand study9 is the first complete national study of mortality from asthma and has identified the largest reported community series of childhood deaths from asthma collected within a short period. We believe our case finding methods detected all childhood deaths from asthma over this period, but as we did not investigate every childhood death, it is possible that mortality from asthma could be even higher. In Avon county, England, 26 of 28 possible cases were detected by a search of death certificates. 4 The present study provides a wider range of deaths than earlier series based on hospital treated patients,98 and more complete information on circumstances surrounding death, including treatment, than was available for cases dying in (37%) or out (63%) of hospital in Avon county. 4 The dominance of Maoris in the under 10 age group and the fivefold increase in mortality from asthma among Maori children is a cause for particular concern. Prevalence rates for asthma in each ethnic group are not yet known, but differences in prevalence could not be great enough to account for a fivefold higher mortality in Maoris. The numbers of deaths are small and are drawn from a small population of 840 000 in this age group, but the rates Deaths from asthma in New Zealand 9 are consistent with the data from the much larger adult New Zealand population.9
The mean age of European children in our study was 12- Many of the factors associated with mortality from asthma in childhood were similar to those found in the British Thoracic Association study of mortality among adults with asthma17-namely, chronic undertreatment, lack of objective assessment of severity, and delay in calling help. Disturbed family circumstances may compound these problems in childhood where clearly parental care and knowledge are of greater importance.
At least 11 of the 16 deaths in children aged under 15 were associated with avoidable factors. Measures that we believe could lower the mortality rate from asthma among children include increased family awareness of asthma and understanding of a crisis plan for dealing with an emergency due to asthma; regular assessment of severity and control with peak flow monitoring; improved access of high risk children with asthma to medical care, including provision for direct hospital admission; and removal of financial barriers, including the cost of ambulances, general practitioner consultations, and peak flowmeters. Improved long term care, including education to accept regular treatment to control abnormal lung function as well as symptoms, may reduce mortality. While further studies are required to prove the benefits of both education and long term treatment this survey of childhood deaths from asthma suggests these are areas for particular action.
